METPROVIB PR 50 METOPROLOL 50mg. IP

Metprovib PR 50 tablets contain Metoprolol 50 mg, a beta-blocker used for high blood pressure and angina. Main uses: treatment of high blood pressure (hypertension) in adults, to lower blood pressure; treatment of angina pectoris (chest pain); after a heart attack (myocardial infarction), to reduce the risk of further cardiovascular problems when advised by a doctor; lowering blood pressure also lowers the risk of stroke and heart attack.

Common side effects of Metprovib PR 50 Tablet include tiredness; dizziness; depression; shortness of breath; slow heart rate (bradycardia); low blood pressure (hypotension). Get medical help at once if you notice worsening heart failure; worsening angina or heart attack; worsening of heart block.

Each Metprovib PR 50 tablet contains Metoprolol 50 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Metprovib PR 50 Tablet only as your doctor advises.

The MRP of Metprovib PR 50 Tablet is ₹62.36 for a pack of 10x10 (Alu Strip). For chemists and distributors, the PTR is ₹47.51 and the PTS is ₹42.76.

Each Metprovib PR 50 tablet contains Metoprolol 50 mg. It comes in a pack of 10x10 (Alu Strip).

The metoprolol in Metprovib PR 50 blocks beta-1 receptors in the heart. This slows the sinus rate and reduces conduction through the AV node, so the heart beats more slowly and with less force. Blood pressure comes down and the workload and oxygen need of the heart muscle are reduced.

Must not be used by anyone allergic to metoprolol or any component of the tablet. Must not be used in severe bradycardia, greater than first-degree heart block, or sick sinus syndrome unless a permanent pacemaker is in place. Must not be used in cardiogenic shock or decompensated heart failure. Must not be used if systolic blood pressure is below 100. Beta-blockers should be avoided in bronchospastic disease such as asthma or similar breathing conditions; see a doctor first before using this medicine in such cases. Also check with a doctor first if you have diabetes, thyrotoxicosis, peripheral vascular disease or pheochromocytoma (treatment for pheochromocytoma should be started with an alpha-blocker first), or if you are planned for major surgery; do not stop the medicine suddenly.

Metprovib PR 50 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.